Peer Review History
| Original SubmissionOctober 15, 2021 |
|---|
|
PONE-D-21-32992Longitudinal Effects of Behavioral Activation Coping Strategies on Depressive Symptoms of U.S. Adults Living Alone during the COVID-19 PandemicPLOS ONE Dear Dr. Kim, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Typically, two reviewers would review a manuscript before an editorial decision; however, given the difficulties finding reviewers and the need for timely decisions, I have elected to move forward with my decision based on Reviewer 1's comments. Reviewer 1 has provided very thorough and detailed feedback on how to improve the manuscript and meet the PLOS ONE publication criteria. In particular, Reviewer 1 highlights some methodological concerns including whether the data are representative, the role of unobserved confounders, and the use of causal language in the context of the current research design. I share Reviewer 1's concerns, and I ask that you do your best to address their comments. Please submit your revised manuscript by Jan 24 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Kenzie Latham-Mintus, PhD, FGSA Academic Editor PLOS ONE Journal Requirements: We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The paper aims to test if behavioral activation coping strategies reduce depressive symptoms during COVID-19 period for adults living alone. Because COVID-19 pandemic had substantial effects on psychological well-beings for adults in the U.S., empirical evidence for the effect of coping strategies on depressive symptoms would tell us how adults in the U.S. can deal with this unusual situation. I also appreciate their focus on those living alone, a potentially vulnerable population. Below are my comments to this study which the authors may have to consider: PLOS ONE's criteria: Experiments, statistics, and other analyses are performed to a high technical standard and are described in sufficient detail. There are several methodological concerns in the current submission. First, although the authors described that the Understanding America Study (UAS) is a nationally representative survey, there is an implausible number in descriptive statistics. Looking at Table 1, among the analytical sample in the current study, 44.12% of respondents hold graduate degree. Given that the percentage of those who have bachelors or higher (not a graduate degree) in Massachusetts (one of the states with the highest proportion of college graduates in the U.S.) is 44%, I suspect that this is too high to consider the dataset is nationally representative. I appreciate it if the authors go back to the data again to confirm whether you do not have any coding mistakes for educational attainment. Relevantly, I could not find whether the authors used appropriate weights to account for the probability to participate in the survey. Because UAS provides sampling weights, they should incorporate them in the analyses. Second, the methodology in this paper cannot make causal claims, though the goal of this paper is very causal (“we hypothesized that four types of behavioral activation coping … would lower the levels of depressive symptoms for those living alone”). Although I recognized that the authors tried to account for time-variant by adding control variables, this is not enough because there could (and should) be unobserved confounders. This is an important limitation in this paper because the paper aims to test whether coping strategies reduces depressive symptom and the authors provided policy implications by assuming that the observed correlation is causation. Here is one example scenario that the observed correlation is not causation. The paper tried to examine the relationship between lagged coping strategies in t-1 and depressive symptom in t; however, the authors did not account for the possibility that the lagged coping strategies in t-1 may be affected by depressive symptom in t-2. This induces a selection issue: less depressed individuals in t-2 are more likely to exercise in t-1; therefore, the authors observed the negative association between exercise in t-1 and depression in t. There are a lot of other scenarios that would show that the analytical strategy in this paper cannot make causal claims. The authors should draw DAG to show their (assumed) data generating process, and explain why their assumption is valid. Alternatively, the authors may be able to use established causal inference techniques to make compelling causal claims. Otherwise, I appreciate it if the authors extensively revise the manuscript to avoid causal languages, including their hypothesis. Third, the sample size is not consistent across the model. In the descriptive statistics, the sample size is 1,321, but the analytical sample in Table 2 is 1,280. The authors should use the same analytical sample. Fourth, I am not sure if listwise deletion is an appropriate approach to treat the missing values in independent variables, though the number of respondents with missing values is small. Probably, it is worth to try multiple-imputation for the robustness check. Furthermore, they explicated that they dropped observations if respondents do not have values for coping strategies, but I would like to hear whether there are no missing values in the other independent variables. Fifth, I am somewhat concerned about the very high PHQ-4 score in Wave I, but there was no such increase afterward. I do understand that this is the first time that COVID-19 cases have drastically increased in the U.S., but why couldn't we see a similar increase afterward. Is it expected? Could you see a similar trend for those not living alone? Are there any studies which found similar results? Finally, I am interested in why the authors included time-invariant variables even though they incorporated fixed effects which should account for time-invariant effects. PLOS ONE's criteria: Conclusions are presented in an appropriate fashion and are supported by the data Overall, the discussion section sounds fine. However, I have several points that I would like the authors to incorporate. First, I would like the authors to add how substantially important exercise is. I understood that exercise is negatively associated with depressive symptoms among those living alone, but the authors did not provide interpretations for the size of coefficients. This discussion will strengthen the argument of policy interventions. I also would like the authors to reconsider the interpretations of non-significant associations between some coping behaviors (i.e., meditation, relaxation, and social connection) and depressive symptoms. The authors speculated that increased sedentary behaviors during the COVID-19 increases the importance of exercise, but this should not be the reason why the authors did not see significant association between the other coping behaviors. Specifically, I do not think that social connection is not associated with depressive symptoms because of the increased seating time. Additionally, I am not sure whether we can generalize these results to another large-scale traumatic event (“Second, these findings … a large-scale traumatic event”). Because COVID-19 pandemic carries unique features (like social distancing), this may be different from, for example, September-11 attacks. I appreciate it if I can hear the justification why the authors can conclude in this way. Further, I did not understand this sentence: “the present study sought to understand how the pandemic influenced the well-being of another high-risk group: adults living alone.” This study does not test the effect of COVID-19 pandemic on depressive symptoms, but examined the association between coping strategies and depressive symptoms during COVID-19 pandemic. Last but not the least, given the above-mentioned causality issue, I appreciate it if the authors avoid causal languages and add this issue as a limitation in the discussion section. PLOS ONE's criteria: The article is presented in an intelligible fashion and is written in standard English In general, the article is presented in an intelligible fashion and is written in standard English. However, as noted in this memo multiple times, the submission is mixing correlation and causation. I could see many causal languages, such as “effect” and “influence,” in the main text. Again, the authors should avoid these causal languages unless they can identify causal effects by using established causal inference techniques. Another thing that I was concerned about is “general population” in the discussion section. The authors compared those living alone to the general population, but I do not understand what the “general population” means. Are those not living alone general population? If so, why can we consider that those living alone are not “general population?” Very minor points: (1) probably, the authors should avoid abbreviations, such as “SNAP eligibility,” (2) probably, the reference #26 is wrong because I found PHQ-15 and PHQ-5 but not PHQ-4, (3) the authors should use a consistent language (e.g., COVID-19 pandemic or COVID-19 epidemic). ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Longitudinal Links between Behavioral Activation Coping Strategies and Depressive Symptoms of U.S. Adults Living Alone during the COVID-19 Pandemic PONE-D-21-32992R1 Dear Dr. Kim, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Kenzie Latham-Mintus, PhD, FGSA Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No |
| Formally Accepted |
|
PONE-D-21-32992R1 Longitudinal Links between Behavioral Activation Coping Strategies and Depressive Symptoms of U.S. Adults Living Alone during the COVID-19 Pandemic Dear Dr. Kim: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Kenzie Latham-Mintus Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .